These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 27383482)

  • 21. Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors.
    Liu Y; Ramírez J; Ratain MJ
    Br J Clin Pharmacol; 2011 Jun; 71(6):917-20. PubMed ID: 21235620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal anti-inflammatory drugs interact with testosterone glucuronidation.
    Sten T; Finel M; Ask B; Rane A; Ekström L
    Steroids; 2009 Nov; 74(12):971-7. PubMed ID: 19643121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.
    He X; Hesse LM; Hazarika S; Masse G; Harmatz JS; Greenblatt DJ; Court MH
    Br J Clin Pharmacol; 2009 Nov; 68(5):721-30. PubMed ID: 19916996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: I. Identification of polymorphisms in the 5'-regulatory and exon 1 regions, and association with human liver UGT1A6 gene expression and glucuronidation.
    Krishnaswamy S; Hao Q; Al-Rohaimi A; Hesse LM; von Moltke LL; Greenblatt DJ; Court MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1331-9. PubMed ID: 15761114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
    Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
    Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paracetamol and Pain Modulation by TRPV1, UGT2B15, SULT1A1 Genotypes: A Randomized Clinical Trial in Healthy Volunteers.
    Pickering G; Creveaux I; Macian N; Pereira B
    Pain Med; 2020 Apr; 21(4):661-669. PubMed ID: 30908574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
    Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
    Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
    Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
    Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Raloxifene glucuronidation in human intestine, kidney, and liver microsomes and in human liver microsomes genotyped for the UGT1A1*28 polymorphism.
    Trdan Lusin T; Trontelj J; Mrhar A
    Drug Metab Dispos; 2011 Dec; 39(12):2347-54. PubMed ID: 21937736
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The contribution of common UGT2B10 and CYP2A6 alleles to variation in nicotine glucuronidation among European Americans.
    Bloom AJ; von Weymarn LB; Martinez M; Bierut LJ; Goate A; Murphy SE
    Pharmacogenet Genomics; 2013 Dec; 23(12):706-16. PubMed ID: 24192532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer.
    Park J; Chen L; Shade K; Lazarus P; Seigne J; Patterson S; Helal M; Pow-Sang J
    J Urol; 2004 Jun; 171(6 Pt 1):2484-8. PubMed ID: 15126881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UGT2B10 genotype influences nicotine glucuronidation, oxidation, and consumption.
    Berg JZ; von Weymarn LB; Thompson EA; Wickham KM; Weisensel NA; Hatsukami DK; Murphy SE
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1423-31. PubMed ID: 20501767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vitro Study on Influences of UGT1A8 Gene Polymorphisms on Mycophenolate Mofetil Metabolism.
    Zhou Z; Lu Y; Song G; Wang Y; Chen J; Xiao C; Zhong L; Sun X; Peng Z; Wang X
    Exp Clin Transplant; 2018 Aug; 16(4):466-472. PubMed ID: 29025387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.
    Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F
    Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
    Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
    Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
    Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
    J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucuronidation of 1'-hydroxyestragole (1'-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9.
    Iyer LV; Ho MN; Shinn WM; Bradford WW; Tanga MJ; Nath SS; Green CE
    Toxicol Sci; 2003 May; 73(1):36-43. PubMed ID: 12657745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of UDP-glucuronosyltransferase 1A8 polymorphism on raloxifene glucuronidation.
    Kokawa Y; Kishi N; Jinno H; Tanaka-Kagawa T; Narimatsu S; Hanioka N
    Eur J Pharm Sci; 2013 May; 49(2):199-205. PubMed ID: 23499758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate.
    Barbier O; Bélanger A
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):259-70. PubMed ID: 18471784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent.
    Stringer F; Scott G; Valbuena M; Kinley J; Nishihara M; Urquhart R
    Eur J Clin Pharmacol; 2013 Mar; 69(3):423-30. PubMed ID: 22960998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.